<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03243942</url>
  </required_header>
  <id_info>
    <org_study_id>15SDG25740015</org_study_id>
    <nct_id>NCT03243942</nct_id>
  </id_info>
  <brief_title>Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement</brief_title>
  <official_title>Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lantheus Medical Imaging</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The fundamental hypothesis of this project is that real-time intracardiac pressures can be
      monitored and quantified noninvasively in humans using a novel contrast-enhanced ultrasound
      technique called subharmonic-aided pressure estimation (SHAPE).This study will use contrast
      echocardiography to assess the accuracy of SHAPE compared to simultaneously acquired
      intracardiac pressures measured invasively during cardiac catheterization. This study is
      designed to verify that contrast echocardiography using the SHAPE method, already proven in a
      canine model and tested in a human pilot study can be used as a surrogate for cardiac
      catheterization with sufficient accuracy to allow clinical applicability in humans.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Agreement between SHAPE and pressure catheter measurements</measure>
    <time_frame>up to 1 day</time_frame>
    <description>Correlation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Error between SHAPE and pressure catheter measurements</measure>
    <time_frame>up to 1 day</time_frame>
    <description>ANOVA/Post-hoc comparisons</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Cardiac Catheterization</condition>
  <condition>Blood Pressure</condition>
  <condition>Heart Ventricles</condition>
  <condition>Echocardiography</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Definity for pressure measurements</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 vials of activated Definity mixed with 50 ml saline. As per manufacturer's recommendation the infusion rate may vary between 4-10 ml/min (to provide diagnostic intracardiac contrast visibility).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Definity</intervention_name>
    <description>Whenever a patient undergoes cardiac catheterization, which routinely includes intracardiac pressure monitoring using a pressure catheter, as part of their standard clinical care and agrees to participate in the study, we will acquire research data. With Definity infusion, SHAPE algorithm will be initiated to determine optimum acoustic pressure. Then, at the optimum acoustic pressure SHAPE specific data will be acquired from the cardiac chambers and aorta synchronously with the pressures recorded by the catheter (as a part of the patient's standard of care). After acquiring the ultrasound imaging data, the remainder of the heart catheterization will be completed by the attending cardiologist according to the patients' standard of care.</description>
    <arm_group_label>Definity for pressure measurements</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be scheduled for a cardiac catheterization procedure

          -  Adult patients over the age of 21

          -  Acceptable baseline echocardiographic images in the supine position

          -  If a female of child-bearing potential, must have a negative pregnancy test

          -  Provide written informed consent

        Exclusion Criteria:

          -  Clinically unstable patients, e.g., those who are clinically in decompensated heart
             failure or having active chest pain or presenting for admission with an unstable
             anginal syndrome

          -  Patients in whom introduction of a catheter into the left ventricle is contraindicated
             or would potentially be dangerous, e.g., patients with active ventricular arrhythmias
             or with significant aortic valve stenosis where crossing the aortic valve may be
             difficult and not clinically necessary

          -  Patients with anatomic right-to-left, bi-directional, or transient right-to-left
             cardiac shunts where Definity could traverse as a bolus

          -  Patients with known hypersensitivity to Definity

          -  Females who are pregnant or nursing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaydev Dave</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jaydev K Dave</last_name>
    <phone>2159554806</phone>
    <email>jaydev.dave@jefferson.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Flemming Forsberg</last_name>
    <phone>2159554870</phone>
    <email>flemming.forsberg@jefferson.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Thomas Jefferson University and Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaydev Dave, PHD</last_name>
      <phone>215-955-4806</phone>
      <email>jaydev.dave@jefferson.edu</email>
    </contact>
    <contact_backup>
      <last_name>Flemming Forsberg, PHD</last_name>
      <phone>2159554870</phone>
      <email>flemming.forsberg@jefferson.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ira S Cohen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Praveen Mehrotra, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Savage, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dave JK, Halldorsdottir VG, Eisenbrey JR, Liu JB, McDonald ME, Dickie K, Leung C, Forsberg F. Noninvasive estimation of dynamic pressures in vitro and in vivo using the subharmonic response from microbubbles. IEEE Trans Ultrason Ferroelectr Freq Control. 2011 Oct;58(10):2056-66. doi: 10.1109/TUFFC.2011.2056.</citation>
    <PMID>21989870</PMID>
  </reference>
  <reference>
    <citation>Dave JK, Halldorsdottir VG, Eisenbrey JR, Forsberg F. Processing of subharmonic signals from ultrasound contrast agents to determine ambient pressures. Ultrason Imaging. 2012 Apr;34(2):81-92.</citation>
    <PMID>22724314</PMID>
  </reference>
  <reference>
    <citation>Dave JK, Halldorsdottir VG, Eisenbrey JR, Merton DA, Liu JB, Machado P, Zhao H, Park S, Dianis S, Chalek CL, Thomenius KE, Brown DB, Forsberg F. On the implementation of an automated acoustic output optimization algorithm for subharmonic aided pressure estimation. Ultrasonics. 2013 Apr;53(4):880-8. doi: 10.1016/j.ultras.2012.12.010. Epub 2013 Jan 2.</citation>
    <PMID>23347593</PMID>
  </reference>
  <reference>
    <citation>Dave JK, Halldorsdottir VG, Eisenbrey JR, Raichlen JS, Liu JB, McDonald ME, Dickie K, Wang S, Leung C, Forsberg F. Subharmonic microbubble emissions for noninvasively tracking right ventricular pressures. Am J Physiol Heart Circ Physiol. 2012 Jul;303(1):H126-32. doi: 10.1152/ajpheart.00560.2011. Epub 2012 May 4.</citation>
    <PMID>22561300</PMID>
  </reference>
  <reference>
    <citation>Dave JK, Halldorsdottir VG, Eisenbrey JR, Raichlen JS, Liu JB, McDonald ME, Dickie K, Wang S, Leung C, Forsberg F. Noninvasive LV pressure estimation using subharmonic emissions from microbubbles. JACC Cardiovasc Imaging. 2012 Jan;5(1):87-92. doi: 10.1016/j.jcmg.2011.08.017.</citation>
    <PMID>22239898</PMID>
  </reference>
  <reference>
    <citation>Eisenbrey JR, Dave JK, Halldorsdottir VG, Merton DA, Miller C, Gonzalez JM, Machado P, Park S, Dianis S, Chalek CL, Kim CE, Baliff JP, Thomenius KE, Brown DB, Navarro V, Forsberg F. Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient. Radiology. 2013 Aug;268(2):581-8. doi: 10.1148/radiol.13121769. Epub 2013 Mar 22.</citation>
    <PMID>23525208</PMID>
  </reference>
  <reference>
    <citation>Forsberg F, Liu JB, Shi WT, Furuse J, Shimizu M, Goldberg BB. In vivo pressure estimation using subharmonic contrast microbubble signals: proof of concept. IEEE Trans Ultrason Ferroelectr Freq Control. 2005 Apr;52(4):581-3.</citation>
    <PMID>16060506</PMID>
  </reference>
  <reference>
    <citation>Halldorsdottir VG, Dave JK, Leodore LM, Eisenbrey JR, Park S, Hall AL, Thomenius K, Forsberg F. Subharmonic contrast microbubble signals for noninvasive pressure estimation under static and dynamic flow conditions. Ultrason Imaging. 2011 Jul;33(3):153-64.</citation>
    <PMID>21842580</PMID>
  </reference>
  <reference>
    <citation>Shi WT, Forsberg F, Raichlen JS, Needleman L, Goldberg BB. Pressure dependence of subharmonic signals from contrast microbubbles. Ultrasound Med Biol. 1999 Feb;25(2):275-83.</citation>
    <PMID>10320317</PMID>
  </reference>
  <reference>
    <citation>Halldorsdottir VG, Dave JK, Eisenbrey JR, Machado P, Zhao H, Liu JB, Merton DA, Forsberg F. Subharmonic aided pressure estimation for monitoring interstitial fluid pressure in tumours--in vitro and in vivo proof of concept. Ultrasonics. 2014 Sep;54(7):1938-44. doi: 10.1016/j.ultras.2014.04.022. Epub 2014 May 6.</citation>
    <PMID>24856899</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2017</study_first_submitted>
  <study_first_submitted_qc>August 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2017</study_first_posted>
  <last_update_submitted>August 4, 2017</last_update_submitted>
  <last_update_submitted_qc>August 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Thomas Jefferson University</investigator_affiliation>
    <investigator_full_name>Jaydev Dave</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>pressure measurements</keyword>
  <keyword>blood pressure</keyword>
  <keyword>contrast echocardiography</keyword>
  <keyword>ventricular pressures</keyword>
  <keyword>catheterization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>This project will generate pressure values in the aorta, and left and right ventricles using the proposed research method (i.e., SHAPE) and using the standard of care (i.e., catheter based pressure values). Additionally peripheral and central pressures will be generated. All of the pressure values will be made available. Further, all ultrasound data obtained for SHAPE measurements will be made available after anonymizing the data-set to remove any patient information.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

